Camlin Fine Sciences Ltd Q2 FY2026 Concall Summary

Key Takeaways

• Volume-led recovery, profit still absent: Revenue rose 8.6% QoQ to ₹460 crores on a 40% volume jump as plants returned to optimum utilisation after a shutdown-hit Q1, but the bottom line stayed near zero.
• Vanillin is a two-speed story: Volumes are on track for 2,500-3,000 tons guidance, yet net realisation is crushed to \$12 by the 50% US tariff; management is betting channel destocking clears by Q4 (US) and Q1 FY27 (Europe) to unlock both volume and price.
• Blends is the growth engine, and it is being fuelled deliberately: A 21% expansion in the field force this quarter, plus the imminent Vinpai consolidation, underpins an 18-20% blends growth target; the payoff from these hires starts showing from Q4.
• Incremental vanillin economics are binary and powerful: All fixed costs are already absorbed, so every additional ton sold at the current \$12 realisation drops a straight \$4 margin to the bottom line, making volume the single biggest profit lever.
• What to watch next quarter: Whether Vinpai closes and begins consolidating, the trajectory of US pet food recovery, and any signal on where US tariffs actually land, since every dollar above or below \$55 shifts net realisation directly.

Vanillin: The Tariff Trap and the Volume Escape

• Volume guidance reaffirmed: The company did ~1,300 tons in H1 and remains confident of hitting 2,500-3,000 tons for the full year, with October-November trends running at a similar quarterly pace of ~700 tons.
• Realisation is a tariff story: The US DDP price is ~\$19-20, but the 50% tariff leaves Camlin with a net realisation of just \$12; Europe fetches \$12-13 without the same tariff drag. Every 1% move in the tariff rate above or below 55% directly moves net realisation.
• Channel destocking is the unlock: US destocking is expected to complete by Q4 FY26; Europe, where anti-dumping duties were levied only in July and channel stocks are large, should clear by Q1 FY27. Demand pickup is timed to those clearings.
• Incremental margin math is compelling: All fixed costs of running the vanillin plant are already in the P&L; RMC sits at ~\$8, so every incremental ton sold at \$12 delivers a straight \$4 margin contribution. At full capacity, unit costs drop further to \$8, widening the spread.
• Next year's volume ambition: Management is already looking at ~4,000 tons for FY27, implying a significant step-up from the current 2,500-3,000 ton run-rate once channel stocks normalise.
• Contracts are short-dated and cautious: Buyers are signing only one-to-two-quarter contracts because they still hold stocks; Camlin has won some H1 calendar-year-27 contracts at DDP prices around \$19.5, with the rest left to the spot market.
• Non-US/Europe markets are written off: Chinese competitors are dumping at \$7-7.50, a price level Camlin refuses to chase; only small F&B volumes move outside the core US-Europe corridor.

Momaya: "All our costs of running the Vanillin plant are in today. Whatever incremental sales that I do on Vanillin, my RMC today is say at roughly about \$8. So, and if my realization is 12, I get a straight \$4 margin on every incremental sale that I do because in these numbers, all my costs today are in, 100% of the costs are in."

Blends: Building the Growth Engine

• Blends growth target set at 18-20%: Management expects to hit this through a combination of increasing blend strength in existing accounts and inorganic contribution from Vinpai, which is expected to close and begin consolidating this quarter.
• Salesforce expansion is aggressive and deliberate: The company added 31 people this quarter, a 21% increase in field force, spread across pet food, animal nutrition, and human food verticals in the US, Brazil, Europe, and India. Earlier hires from Q1 will also start contributing from Q4.
• Payoff timeline is six months: New sales hires typically take six months to show impact, so the current-quarter additions will begin contributing by Q4 FY26 and Q1 FY27; management is projecting at least 20% growth next year from the 20% headcount addition.
• Vinpai acquisition is at the finish line: Share-swap approval from stock exchanges is expected by November-end, with the swap completing within 15 days thereafter; Vinpai becomes a subsidiary this quarter and brings additional revenue, with its own hiring plans underway.
• US blends dip was partly optical: The North America revenue drop from ₹96 to ₹69 crores was not purely a blends decline; last quarter routed vanillin sales through the US for better margins, while this quarter used direct sales to avoid working capital and duty drag. Underlying blends were down only ~5% on animal nutrition softness. [7-8]
• US pet food is turning: The pet food slowdown that hurt the last two quarters is now improving, and the business is expected to be back on track.

Profitability: The Waiting Game

• Gross margin recovered to ~46%: Up from 43-44% last quarter as plants returned to optimum utilisation after shutdowns; Tarapur ran at over 40% higher volumes and vanillin volumes rose 35%.
• Bottom line still at breakeven: The company moved from a loss last quarter to near-zero profit this quarter, with improvement expected in subsequent quarters as volume leverage kicks in.
• Employee costs are elevated but stable going forward: Current-quarter employee costs absorbed ~20 new blends marketing hires across regions; a one-time bonus paid last quarter masks the underlying increase. Management expects employee costs to stay at this level, with only small percentage increases as more marketing heads are added.
• Discontinued operations are a fading drag: The mothballed European diphenol plant and associated costs will run ~₹25 crores this year, dropping to ~₹2 crores per quarter from next year; China liquidation is already initiated and will carry zero cost from FY27.
• Balance sheet is steady: No major capex beyond maintenance; gross debt stable; net debt rose from ₹490 to ₹520 crores as rights-issue proceeds were deployed; interest costs have not moved materially net of fixed costs.

Competitive Landscape and Strategy

• Syensqo restart is a known variable: Syensqo has 5,000 tons of capacity serving a European market of 8,000-8,500 tons, leaving a 3,500-ton import gap that Camlin is positioning to fill.
• US remains the strategic priority: Management is not changing its geographic strategy; the US is the larger market and will always command a bigger share of the mix. With Trump-era tariffs in place, the immediate priority is filling existing capacity first before revisiting strategy.
• Local competition pressures straights: TBHQ and BHA face heightened local competition in India, putting pressure on realisations even as costs remain stable; the company is holding volumes but absorbing margin compression in this segment.
• Contract structures determine tariff pass-through speed: DDP contracts pass tariff changes through immediately; CIF contracts lock in pricing until the next contract cycle, delaying the adjustment.

Momaya: "The de-stocking in the US is expected to be completed by Q4 of this year. And in Europe, it is expected to be cleared by Q1 of FY'27. Because Europe, the anti-dumping duty was levied only in July. So there was a large amount of channel stocks lying in Europe."

Guidance & Commitments

Key Metrics